Design Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Carlsbad, California, focused on pioneering therapies for degenerative disorders associated with nucleotide repeat expansions, such as Friedreich's ataxia. The company is advancing a proprietary pipeline of small-molecule drug candidates aimed at addressing the underlying genetic mechanisms of these diseases to restore normal cellular function and improve patient outcomes. With a commitment to tackling significant unmet medical needs, Design Therapeutics is strategically positioned to impact the biopharmaceutical landscape, especially in the niche of rare genetic diseases. Show more

Location: 6005 HIDDEN VALLEY ROAD, CARLSBAD, CA, UNITED STATES, 92011, Carlsbad, CA, 92011, USA | Website: https://www.designtx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

581.6M

52 Wk Range

$2.60 - $10.97

Previous Close

$10.57

Open

$10.48

Volume

453,530

Day Range

$9.82 - $10.69

Enterprise Value

397.9M

Cash

15.09M

Avg Qtr Burn

-11.16M

Insider Ownership

35.97%

Institutional Own.

59.27%

Qtr Updated

09/30/25